Eating Disorders News

The American Diabetes Association recently updated its Standards of Medical Care in Diabetes to underscore new drug recommendations for patients with diabetes, cardiovascular outcomes trials, psychosocial health and bariatric surgery.

Recent findings indicated that a higher level of eating disorder symptoms at age 9 years predicted a higher level of symptoms at age 12 years, suggesting the importance of early interventions before age 9 years.

In patients with anorexia nervosa, the risk for fracture is increased in men older than 40 years and in women of all ages compared with people without the eating disorder, study data show.

Approximately two-thirds of females with eating disorders recovered by age 22 years and recovery while bulimia nervosa occurred earlier, recovery from anorexia nervosa continued over the long-term, according to recent findings.

The American Diabetes Association’s updated 2017 Standards of Medical Care in Diabetes includes several new updates that will affect patient care, including new drug recommendations for patients with diabetes and cardiovascular disease, updated bariatric surgery guidelines and a focus on psychosocial health.

Reduced exposure to TV food advertisements in preschool-aged children may decrease the priming and reinforcement of dietary behavior that lead to obesity and energy-dense food preferences, according to published study findings in the journal Pediatrics.

Group therapy delivered through an online chat group was effective for bulimia nervosa, but had a slower recovery compared with in-person group therapy, according to recent findings.

NEW ORLEANS — Binge eating during adolescence may be predicted by eating in the absence of hunger during childhood, study data show.

SAN FRANCISCO — Parents and health care providers should work together to construct a Family Media Use Plan for children aged 5 to 18 years that considers the child’s health, temperament and developmental stage, according to an AAP policy statement published in conjunction with the 2016 AAP National Conference and Exhibition.

The FDA recently approved a supplemental New Drug Application to update the U.S. labeling of Vyvanse to include new long-term maintenance data in adults with moderate or severe binge eating disorder, according to a press release from the manufacturer.